News Releases

October 2018

October 8, 2018 10/8/2018 New Real-World Data Analyses Support the Long-Term Use of Entyvio® (vedolizumab) in Bio-Naïve Patients

October 5, 2018 10/5/2018 Takeda Donates more than $130,000 to Local, Regional Charities at Annual Takeda Cares Day Event

September 2018

September 26, 2018 9/26/2018 Working Mother Names Takeda As One Of The 2018 100 Best Companies

June 2018

June 15, 2018 6/15/2018 Takeda Further Expands Help At Hand Patient Assistance Program in U.S.

June 3, 2018 6/3/2018 Takeda Highlights Favorable Safety Profile of Entyvio® (vedolizumab) Through Comparative Real-World Data Versus TNFα-Antagonist Therapy in Ulcerative Colitis and Crohn’s Disease

May 2018

May 24, 2018 5/24/2018 Takeda Supports Illinois Bicentennial Stem Fusion Program

May 5, 2018 5/5/2018 Takeda Activities at American Psychiatric Association (APA) Annual Meeting Innovation Zone Highlight Advancements in Mental Health

May 2, 2018 5/2/2018 TRINTELLIX® (vortioxetine) Prescribing Information Now Includes New Data Showing Improvement in Processing Speed, an Important Aspect of Cognitive Function in Acute Major Depressive Disorder (MDD)